[Secondary parkinsonian syndromes]
- PMID: 12773887
[Secondary parkinsonian syndromes]
Abstract
Secondary parkinsonism (SP) is caused by an identified structural, toxic, or metabolic mechanism. The first group of SP syndromes includes disorders caused by a primary pathological process in the brain. The second group includes disorders with a primary extrinsic or ubiquitous causal factor resulting either from reversible dysfunction of the basal ganglia or structural disorders related to the predominant or selective vulnerability to aggression of the basal ganglia. The pathophysiological aspects SP are developed here, particularly vascular syndromes and syndromes secondary to hydrocephalus. In both conditions, it is rare that SP resembles Parkinson's disease. The pathophysiology is poorly understood, but would involve, in most cases, corticostratial and/or thalamocortical connections in the basal ganglia system. For the clinician, the practical problem is frequently to determine whether a patient's parkinsonism can be related to an identifiable cause or whether there is an associated Parkinson's disease or other degenerative disease. When both a known cause of parkinsonism and Parkinson's disease are present, the cause may be asymptomatic, reveal Parkinson's disease, have an aggravating effect on the underlying disease, or modify its clinical expression.
Similar articles
-
Other causes of parkinsonism.Baillieres Clin Neurol. 1997 Apr;6(1):205-18. Baillieres Clin Neurol. 1997. PMID: 9426876 Review.
-
[Parkinson's disease and parkinsonian syndromes].Rev Prat. 1989 Mar 9;39(8):647-51. Rev Prat. 1989. PMID: 2727571 French.
-
Basal ganglia oscillations and pathophysiology of movement disorders.Curr Opin Neurobiol. 2006 Dec;16(6):629-37. doi: 10.1016/j.conb.2006.10.002. Epub 2006 Nov 3. Curr Opin Neurobiol. 2006. PMID: 17084615 Review.
-
Is it Parkinson's disease?Aust Fam Physician. 1992 Oct;21(10):1411-6. Aust Fam Physician. 1992. PMID: 1444967 Review.
-
Iron metabolism in Parkinsonian syndromes.Mov Disord. 2006 Sep;21(9):1299-310. doi: 10.1002/mds.21020. Mov Disord. 2006. PMID: 16817199 Review.
Cited by
-
Parkinsonism and chronic manganese exposure: Pilot study with clinical, environmental and experimental evidence.Clin Park Relat Disord. 2020 May 6;3:100057. doi: 10.1016/j.prdoa.2020.100057. eCollection 2020. Clin Park Relat Disord. 2020. PMID: 34316640 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources